Skip to content

Author

R. Condorelli

We have 6 of 424 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Iron Deficiency in Endocrine Diseases and the Therapeutic Role of Liposomal Iron: A Comprehensive Review

Iron deficiency (ID) represents one of the most prevalent nutritional disorders worldwide, affecting approximately 1.2 billion individuals. Beyond its well-established hematological consequences, emerging evidence demonstrates that ID profoundly impacts endocrine function across multiple organ systems. Iron serves as a...

S. La Vignera, R. Condorelli · 0 citations
Review Open access Aug 2026

Gender Differences in Diabetes Technology: Adherence and Outcomes—A Systematic Review

Background/Objectives: Diabetes management technologies—including continuous glucose monitors (CGM), insulin pumps (CSII), advanced hybrid closed-loop (AHCL) systems, and mobile health applications—have transformed diabetes care, yet gender-specific differences in ad-herence, clinical outcomes, and patient-reported out...

S. La Vignera, A. Calogero, R. Cannarella et al. · 0 citations
Case report Open access Sep 2026

Tirzepatide non-response with subsequent semaglutide response in class 2 obesity.

This case challenges the assumption that dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonism is universally superior to selective GLP-1 receptor agonism for weight management and supports precision medicine approaches in obesity pharmacotherapy.

S. La Vignera, R. Condorelli · 1 citation
Review Open access Jul 2026

Is Male Hypogonadism a Risk Factor for Cancer Through Weakening of the Immune System?

Current evidence on the relationship between male hypogonadism, immune function, and cancer risk is reviewed, focusing on mechanisms linking testosterone deficiency to immune suppression and oncologic outcomes.

S. La Vignera, R. Condorelli · 0 citations
Open access Jul 2026

Effect of Active Insulin Time and Glycemic Targets on Automatic Correction Bolus Delivery.

Active insulin time is a key modifiable parameter influencing AB delivery and glycemic outcomes, and shorter AIT settings were associated with increased AB administration and improved TIR, whereas glucose target settings had no significant impact on these outcomes.

Giuseppe Papa, R. Cannarella, C. Gusmano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.